Introduction
============

Breast cancer (BC) is the second most common cancer worldwide and the most frequent cancer among women (25% of the overall cancer among women) with an increasing incidence in the last decade. The World Health Organization (WHO) ranked BC as the fifth most common cause of cancer mortality worldwide (522,000 deaths in 2012) (Torre et al., 2015). The significant improvements in BC screening, diagnosis, and treatment over the past few decades led to a decline in BC-related death rate, which in turn caused a substantial increase in the number of BC survivors (Siegel et al., 2017).

Physical activity plays a significant role in improving quality of life (QoL), physical, psychological functions, and other health indicators in cancer patients (Fong et al., 2012). The literature showed several benefits for exercise therapy as a supportive care for BC patients and survivors (Brockow et al., 2016; Kim et al., 2009; McNeely et al., 2006a) These beneficial effects vary according to disease stage, type of primary treatment and the lifestyle of patients (Knols et al., 2005)

The survival outcome in BC survivors is likely to have some correlation with exercise; long-term physical activity levels are important for BC prognosis and are associated with improved survival (Bertram et al., 2011). Moreover, previous research showed that exercise improves the QoL and lessens the symptoms of depression and anxiety in BC survivors (Segar et al., 1998). Additionally, it was associated with benefits on muscle strength and body composition (Zhu et al., 2016). Therefore, the American Cancer Society guidelines recommend at least 150 minutes on a weekly basis for exercise practicing. These guidelines also encouraged long-term adherence to daily exercise beyond the initial post-surgical rehabilitation (Rock et al., 2012).

Aerobic exercise is a form of physical activity that depends primarily on the aerobic energy-generating process i.e. it requires free oxygen to meet the demands of aerobic metabolism. It involves running/jogging, swimming, cycling, and walking. Several randomized controlled trials (RCTs) suggested the efficacy of aerobic exercise in reducing cancer-related fatigue among BC survivors (Cantarero-Villanueva et al., 2013; Carter et al., 2016; Vardar Yağlı et al., 2015). Moreover, aerobic physical activity was found effective in improving anthropometric measures as body weight, body composition, and VO2 peak, as well as reducing inflammatory markers (Jones et al., 2013; Matthews et al., 2007; Tizdast et al.,2016)..

The benefits of exercise in general in BC survivors have been assessed in several systematic reviews and meta-analyses (Floyd and Moyer, 2010; Meneses-Echávez et al., 2015; Zhu et al., 2016). However, there is a gap in addressing the effects of specific exercise types in BC rehabilitation program as published trials showed conflicting results, especially in terms of physical activity and QoL outcomes. According to our knowledge, no former systematic review or meta-analysis has assessed the benefits of aerobic exercise specifically in BC survivors. The National Comprehensive Cancer Network (NCCN) reported the need for future research work to identify the effects of specific modes of exercise on specific outcomes as fatigue and QoL in cancer survivors (Schmitz et al., 2010).

We performed this systematic review of the literature to investigate the efficacy of aerobic exercise intervention on physical activity, QoL (primary outcomes), weight, inflammatory markers and sleep among BC survivors by scrutinizing the published trials.

Materials and Methods
=====================

We followed the PRISMA statement guidelines (Table S1 of Supplementary material) during the preparation of this review (Moher et al., 2009). This systematic review is registered on the PROSPERO international prospective register of systematic reviews (CRD42017060106).

*Literature search strategy*

We searched PubMed https://www.ncbi.nlm.nih.gov/pubmed/, Web of knowledge http.apps.webofknowledge.com, Scopus https-www-scopus.com, Cochrane Central https://www.cochranelibrary.com/central, Virtual Health Library (VHL) https://bvsalud.org/en/ and PEDRO https://www.pedro.org.au/ for RCTs that compared Aerobic Exercise with usual care in BC survivors. We used the following search strategy "(breast cancer survivors\* OR breast tumor survivors\*) AND (Aerobic exercise OR physical fitness OR physical therapy OR rehabilitation)". No restrictions by publication period were employed.. In addition, we manually scanned the references list of selected articles for relevant studies.

*Eligibility criteria and study selection*

We included RCTs that met our inclusion criteria, a) Population: BC survivor women, treated with chemotherapy or radiotherapy (stopped at least six months earlier) or patients who have started adjuvant endocrine therapy (antiestrogens, aromatase inhibitors, LHRH agonists, or combinations) not less than 4 months earlier and not scheduled for and not currently undergoing chemo-/radiation therapy, b) Intervention: Studies in which the intervention was aerobic exercise (walking, cycle ergometers, swimming, and stair climbing), not mixed with any other type of exercise, c) Comparator: Studies where the control group received usual care, d) Outcomes: Physical Activity level, QoL, Sleep parameters, weight, as well as inflammatory markers.

We excluded studies with the following criteria: a) patients on active therapy, b) patients with uncontrolled cardiac or vascular disease, c) patients exercising at a regular basis at baseline, and d) non-English articles. The retrieved citations were added to a Microsoft Excel sheet that was distributed to reviewers. Eligibility screening was done through two separate steps: a) titles and abstracts screening, and b) full texts screening. Each study title and/or full-text was screened by two independent reviewers (therefore, each reviewer screened half the retrieved citations) and disagreements were resolved by discussion between all reviewers.

*Data Extraction*

Three independent reviewers extracted the relevant data from the included studies, using a preformatted data extraction sheet. Disagreements were resolved by the opinion of a fourth reviewer. The extracted data included: a) baseline characteristics of participants as age and cancer stage, b) general characteristics of included studies as design, sample size, and assessed outcomes, c) characteristics of the intervention as type, intensity, and duration and d) the results of each included study. The summary effect size was difficult to calculate due to the lack of sufficient data for subsequent pooling, as well as lack of the homogeneity needed to make a calculation.

*Risk of bias assessment*

The risk of bias in included RCTs was assessed according to the Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 (updated March 2011) using the risk of bias assessment table, provided in the same book (part 2, Chapter 8.5). The Cochrane risk of bias assessment tool includes the following domains: Random sequence generation (selection bias), allocation sequence concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias), and other potential sources of bias. The reviewer judgment is categorized as low risk, high risk, or unclear risk of bias. For risk of bias exclusion across the included studies, we compared the reported outcomes between the studies to exclude reporting of selective outcome.

Results
=======

*Literature search results*

We retrieved 1,800 unique citations. After the initial title and abstract screening, 86 full-text articles were retrieved and screened for eligibility. After full text screening, 12 RCTs (n= 1,120 patients) were included in our systematic review (see PRISMA flow diagram; [Figure 1](#F1){ref-type="fig"}).

*Characteristic of included studies*

The sample size of included studied ranged from 19 to 357 patients, with an average age of 44 to 61 years. Aerobic exercise was the only intervention of interest in this meta-analysis either supervised or home-based training programs. Most of the included studies reported walking as the preferred type of activity among BC survivors. Exercise sessions were of moderate intensity. Irwin et al., (2008), Matthews et al., (2007) and Saarto et al., (2012) assessed physical activity outcome, while Campbell et al., (2017), Murtezani et al., (2014) and Saarto et al., (2012) examined the effect of aerobic exercise on the QoL. Murtezani et al., (2014), Roveda et al., (2016) and Tizdast et al., (2016) investigated the role of aerobic exercise on weight reduction among BC survivors. Two studies assessed the effect of aerobic exercise on inflammatory markers (Fairey et al., 2005; Jones et al., 2013). Only one study reported the effect of aerobic exercise on sleep parameters (Roveda et al., 2016). A summary of the design and main findings of included studies is shown in [Table 1](#T1){ref-type="table"}, and the baseline characteristics of their participants are shown in [Table 2](#T2){ref-type="table"}.

*Risk of Bias assessment results*

We used the Cochrane risk of bias assessment tool to assess the bias of included studies. All included studies were of low risk in terms of selective reporting and attrition bias. Only five studies were of low risk of bias in terms of allocation concealment (Carter et al., 2016; Irwin et al., 2008; Murtezani et al., 2014; Roveda et al., 2016; Saarto et al., 2012), while three studies were of low risk of bias in terms of blinding the participants/personnel (Campbell et al., 2017; Fairey et al., 2005; Jones et al., 2013). The summary of risk of bias assessment is shown in [Figure 2](#F2){ref-type="fig"}, and the reasons for authors' judgments are shown in Table S2 of Supplementary material.

*Physical Activity*

Mathews et al., (2007) reported higher activity levels in the intervention group compared to usual care group (p ≤0.04). Moreover, Irwin et al., (2008) reported that in the 7-day physical activity log, the exercise group increased from moderate to vigorous intensity reactional activity (129 min per week, p \<0.001), compared to a smaller increase in the usual care group (45 min per week). However, Saarto et al., (2012) reported an insignificant difference between the exercise and control groups (P=0.97). They detected a significant linear trend between higher physical activity, improved QoL, and recovery from fatigue.

*Quality of life*

Saarto et al., (2012) measured the QoL using the EORTC-QIQ-C30 or BR-23 forms. They reported no significant difference after 12 months in QoL between exercise and control groups. Campbell et al., (2017) used the FACT-COG tool to measure the cognitive symptoms impacting the QoL, but they found no statistically significant improvement. Murtezani et al., (2014) used the FACT B score to measure the overall QoL after 10 weeks of intervention. They reported that the FACT B score was increased in the intervention group and was decreased in controls (P = 0.003).

*Weight*

Tizdast et al., (2016) reported that higher weight reduction was achieved in the interval exercise group (P=0.012). Murtezani et al., (2014) and Fairy et al., (2005) did not observe any significant difference between the exercise and control groups in terms of weight loss (95% CI,-4.8 to 2.25 Kg; P=0.47 and 95% CI,-1.6 to 0.6 Kg; P=0.39, respectively). On the contrary, Roveda et al., (2016) found that the control group had a significant weight reduction after 3 months of physical activity (P= 0.01).

*Inflammatory markers*

Two studies examined the effects of aerobic exercise on inflammatory makers in BC survivors. Fairy et al., (2005) reported that C-reactive protein (CRP) decreased by 139 mg/l in the exercise group, while it increased by 0.1 mg/l in the control group. However, this change was not significant (95% CI,-3.09 to 0.1 mg/l; P=0.66) Moreover, Jones et al. (2013) reported an insignificant difference between randomization groups regarding serum concentrations of interleukin (IL)-6, CRP, and tumor necrosis factor (TNF-α).

*Sleep parameters*

Only one study reported the effects of exercise on sleep parameters for BC survivors. Roveda et al., (2016) found sleep efficiency (SE) to be significantly decreased in the control group, it but remained unchanged in the exercise group (P=0.001). The mean activity score (MAS) was significantly increased in the control group, but it remained unchanged in the exercise group (p \<0.001). The authors reported a significant decrease (P=0.03) in the actual sleep time (AST) and a significant increase (P=0.02) in the movement fragmentation index (MFI) after aerobic exercise intervention, compared to baseline scores.

###### 

Shows a Summary of the Design and Main Findings of Included Studies

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  study ID         Population\                                                 Mean age (SD)\                   sample size\                                                                       duration of treatment   Type of Exercise\                                                                                                 intensity                                    frequency                                                                                                                                               Outcomes measured                                                                                                                           Summary of results
                   (cancer stage)                                              Intervention/control             intervention/control groups                                                                                Intervention/control                                                                                                                                                                                                                                                                                                                                                                                                                                               
  ---------------- ----------------------------------------------------------- -------------------------------- ---------------------------------------------------------------------------------- ----------------------- ----------------------------------------------------------------------------------------------------------------- -------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Matthews 2007    Stage I--III breast cancer                                  51.3 (9.0) / 56.9 (12.3)         22 / 14                                                                            12 weeks                Walking / Usual care                                                                                              Moderate                                     \*In the first 4 weeks, three times/week.\                                                                                                              \* Overall physical activity level measured by CHAMPS questionnaire (MET-h/week) and the actigraph.\                                        \* Intervention proved effective in increasing physical activity levels among breast cancer survivors.\
                                                                                                                                                                                                                                                                                                                                                                                          \*5--7 weeks, four times/week\                                                                                                                          \*Effect of intervention on physical activity behaviors and body composition measured by (body mass, Fat-free mass , fat mass, body fat).   \*No significant changes in body fat and composition.
                                                                                                                                                                                                                                                                                                                                                                                          \*The final 5 weeks, five times/week                                                                                                                                                                                                                                                                

  Campbell 2017    stage I-IIIA breast cancer                                  53.2 (7.0) / 51.4 (5.1)          10/9                                                                               24 weeks                Walking / usual lifestyle                                                                                         Moderate-to-vigorous                         150 min/week of aerobic exercise + two 45-minute supervised sessions per week in a research gym + two additional 30 minute unsupervised home sessions   \*Self-reported cognitive dysfunction and associated impact on quality of life measured by (FACT-Cog).\                                     No statistically significant improvement in self-reported cognitive function and neuropsychological tests.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*Objective neuropsychological tests in cancer survivors based on TMT-A and TMT-B, Stroop test, fMRI.                                       

  Roveda 2016      NR                                                          55.2 (6.8) / 58.2 (6.4)          19 / 21                                                                            3 months                Brisk walking\                                                                                                    Moderate                                     2 sessions of\                                                                                                                                          \*Anthropometric and Body Composition\                                                                                                      aerobic PA has\
                                                                                                                                                                                                                           .                                                                                                                                                              1-hour brisk walking per week                                                                                                                           Evaluation\                                                                                                                                 a protective effect against factors promoting sleep disruption.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*Actigraphic Monitoring of Sleep Patterns\                                                                                                 PA improved sleep behavior and reduced sleep worsening of BCS.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*Actigraphic Monitoring of Activity Level and\                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Circadian Rhythm\                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*Armband-Based Monitoring of Energy\                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Expenditure                                                                                                                                 

  Fairey 2005      Stage I-IIIA breast cancer                                  59 (5) / 58 (6)                  24 / 28                                                                            15 weeks                cycle ergometers / no activity                                                                                    Moderate                                     3 times per week                                                                                                                                        \*Effect of PA on CRP\                                                                                                                      \*PA had borderline significant effect on CRP\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \* Effect of PA on cardiovascular\                                                                                                          \*PA also had a clinically and statistically\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  risk factors (RHR, HRR, SBP, DBP, TC, LDL-C, HDL-C, TG, and TC:HDL-C ratio).                                                                significant effect on HRR and clinically but not statistically significant effects on RHR, SBP, DBP,\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              HDL-C, and TG

  Thomas 2013      Stage 0--111A breast cancer                                 56.5 (9.8) / 55.1 (7.6)          35 / 30                                                                            6 months                Walking / usual care                                                                                              Moderate\                                    \*Three 15-minute sessions (week1)\                                                                                                                     Effect of aerobic exercise on metabolic syndrome prevalence\                                                                                \*In overweight or obese, physically inactive BCS\
                                                                                                                                                                                                                                                                                                                                             intensity                                    \* gradually built up to five 30-minute\                                                                                                                - Waist circumference (cm)\                                                                                                                 the adherence to a moderate intensity\
                                                                                                                                                                                                                                                                                                                                                                                          (Week 5)                                                                                                                                                - HDL-C (mg/dL)\                                                                                                                            aerobic exercise was associated with improvements\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  -Triglycerides (mg/dL)\                                                                                                                     in metabolic syndrome criteria.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  - Glucose (mg/dL)\                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  - Metabolic syndrome z-score                                                                                                                

  Murtezani 2014                                                               53 ( 11) / 51( 11)               30/32                                                                              10 week                 Aerobic exercise(treadmills, stationary bicycles, and stairclimbing\                                              Moderate\                                    three times per week for 10 weeks                                                                                                                       \*-Anthropometric\                                                                                                                          Results revealed that 10 week of moderateintensity aerobic exercise program significantly improves QOL and physical functioning in breast cancer survivors
                                                                                                                                                                                                                           Machines) / usual care                                                                                            intensity                                                                                                                                                                                            Changes\                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  a) BMI\                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  b) % Total body fat\                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*-Quality of life assessment by (FACTB)\                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*12 min\                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  walk test.                                                                                                                                  

  study ID         Population\                                                 Mean age (SD)\                   sample size\                                                                       duration of treatment   Type of Exercise\                                                                                                 intensity                                    frequency                                                                                                                                               Outcomes measured                                                                                                                           Summary of results
                   (cancer stage)                                              Intervention/control             intervention/control groups                                                                                Intervention/control                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Carter 2016      DCIS or stage I-IIIA breast cancer                          55(8) for all participants       76/76                                                                              3 months                treadmill walking/usual care                                                                                      Vigrous-Moderate\                            -goal of meeting ≥150 min of\                                                                                                                           -baseline and immediately postintervention\                                                                                                 Lower rate-pressure product during submaximal walking was\
                                                                                                                                                                                                                                                                                                                                             intensity                                    moderate-intensityexercise\                                                                                                                             (M3) on measures of physical activity\                                                                                                      significantly associated with reduced fatigue in BCS.\
                                                                                                                                                                                                                                                                                                                                                                                          -less than 30 min\                                                                                                                                      (accelerometry), graded walk test, and average fatigue over\                                                                                for Cancer Survivors Exercise/physical activity\
                                                                                                                                                                                                                                                                                                                                                                                          of vigorous or 60 min of self-reported moderate-\                                                                                                       the previous 7 days.\                                                                                                                       training programs that lower the physiological strain during\
                                                                                                                                                                                                                                                                                                                                                                                          intensity physical activity per week.                                                                                                                   -calculating Pressure product rate (PPR)                                                                                                    submaximal walking may produce the largest improvements\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              in reported fatigue.

  Saarto 2012      Histologically proven invasive breast cancer T1-4,N0-3,M0   Mean age (range)\                263/237                                                                            12 months               supervised and home training\                                                                                     progressive vigorous exercise training\      -supervised training: once a\                                                                                                                           Changes in quality of life (QoL) during the intervention measured by the\                                                                   \*The amount of physical\
                                                                               52.3(36-68)/52.4(35-68)                                                                                                                     -supervised training: endurance training such as walking, Nordic walking or aerobic training, jumps and leaps.\                                                week 60-minute\                                                                                                                                         \* EORTC QLQ-C30 and \*BR-23\                                                                                                               activity increased from baseline to 12 months\
                                                                                                                                                                                                                           In addition, brisk endurance training (walking,\                                                                                                               aerobics and circuit training                                                                                                                           \*FACIT-F\                                                                                                                                  \*Neuromuscular performance improved significantly in the\
                                                                                                                                                                                                                           Cycling, swimming etc.)                                                                                                                                                                                                                                                                                                BDI questionnaires                                                                                                                          training group\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \*No significant effect of the intervention was observed on\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              cardiorespiratory fitness.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \*No significant difference was found between the\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              exercise and control groups in changes of QoL during the\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              intervention

  Segar 1998       Any type of breast cancer surgery                           47.5(7.1)/61.8(8.1)              16/8                                                                               10 weeks                Exercise group / Exercise plus Behavior / control group\                                                          =\< 60 of age predicted maximum heart rate   a minimum 30 minutes/seesion,\                                                                                                                          \*Exercise adherence\                                                                                                                       \*women who exercised had signficantly less depression and state and anxiety over time compared to control\
                                                                                                                                                                                                                           ((study participant choose her favorite and most conveient type of aerobic exercise))                                                                          4 days/week                                                                                                                                             \*Depression (Beck depresion Inventory)\                                                                                                    \*after crossover,the control group demonstrated comperable improvement in both depressive and state anxiety scores, self esteem didn\`t changed significantly\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*Anxiety(spellberger stat trait Anxiety inventory)\                                                                                        \*subjects wh recieved exercise recommendation from their physcian exercised significantly more than subjects who recieved no recommendation
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*Rosenberg selfesteem inventory                                                                                                            

  Jones 2012       stage0 to IIIA                                              56.4 (9.6)/ 55.4(7.6)            36/32                                                                              6 months                Aerobic exercise/ usual care                                                                                      moderate- intensity aerobic exercise         150 minutes over 3 weeks                                                                                                                                1-Arthopometric\                                                                                                                            Results revealed that the moderate-intensity\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Changes\                                                                                                                                    aerobic exercise intervention did not signiﬁcantly alter concentrations of IL-6, CRP, or TNF-a.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  c) BMI\                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  d) % Total body fat\                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2- Changes in inflammatory markers Levels.                                                                                                  

  study ID         Population\                                                 Mean age (SD)\                   sample size\                                                                       duration of treatment   Type of Exercise\                                                                                                 intensity                                    frequency                                                                                                                                               Outcomes measured                                                                                                                           Summary of results
                   (cancer stage)                                              Intervention/control             intervention/control groups                                                                                Intervention/control                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Tizdast 2016     stage I-III breast cancer\                                  44.1(4.6) for all participants   continous exercise grpup(n=9), interval exercise group (n=9), control group(n=9)   8 weeks                 Continuous exercise group/ Interval exercise group/ control group\                                                varied according to trainng schedule         three times per week                                                                                                                                    \*Body weight,\                                                                                                                             \*The highest reduction in weight, body fat percentage and adipose tissue and the highest increase in VO2 peak occurred in the interval exercise group.\
                   The Yale Exercise and Survivorship Study.                                                                                                                                                               (planned treadmill exercise))                                                                                                                                                                                                                                                                                          \*body mass index,\                                                                                                                         \*The waist-hip ratio\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*adipose tissue, body fat percentage\                                                                                                      reduced equally in both exercise groups\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \*Waist to Hip Ratio(WHR)                                                                                                                   \*The anthropometric variables, body fat percentage and adipose tissue decreased significantly in\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              both exercise groups but the differencebetween the two exercise groups was not significant

  Irwin 2008       stage 0 (in situ) to stage IIIA breast cancer               56.5 ( 9.5) /55.1 ( 7.7 )        37/38                                                                              6 months                                                                                                                                  Moderate\                                    150 min/wk. of supervised gym-based and home-based aerobic\                                                                                             1-Arthopometric\                                                                                                                            Women in the exercise-intervention group increased their average pedometer steps by 1621 steps per day compared with a decrease of 60 steps per day among women in the usual-care group (P \<.01).
                                                                                                                                                                                                                                                                                                                                             To vigorous intensity                        exercise.\                                                                                                                                              Changes\                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                          44 min/wk. among usual-care to maintain current\                                                                                                        a) BMI\                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                          physical activity level.                                                                                                                                b) % Total body fat\                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2- Satisfaction and competence questionnaire.                                                                                               

  Irwin 2009 (1)   stage 0 to IIIA breast cancer                               56.4 ( 9.5) /55.6 (7.7)          37/38                                                                              6 months                                                                                                                                  moderate-intensity aerobic exercise          150 minutes per week\                                                                                                                                   1-Arthopometric\                                                                                                                            Moderate-intensity aerobic exercise, per week, used in the study is proved to be tolerated in breast cancer survivors and efficacious in decreasing levels of IGF-I and IGFBP-3.
                                                                                                                                                                                                                                                                                                                                                                                          30 minutes on 5 days                                                                                                                                    Changes\                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  c) BMI\                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  d) % Total body fat\                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2- Changes in insulin, IGF-1, IGFBP3 Levels.                                                                                                

  Irwin 2009 (2)   Stage 0--IIIA                                               56.5 (9.5)/ 55.1( 7.7)           37/38                                                                              6 months                                                                                                                                  Moderate\                                    150 min/week\                                                                                                                                           1-Arthopometric\                                                                                                                            Aerobic exercise, such as brisk walking, was associated with\
                                                                                                                                                                                                                                                                                                                                             intensity aerobic exercise                   .                                                                                                                                                       Changes\                                                                                                                                    favorable changes in body fat and LBM, and maintenance of\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  g) BMI\                                                                                                                                     BMD in postmenopausal breast cancer survivors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  h) % Total body fat\                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2-Changes in inflammatory markers Levels.\                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  (BMD)                                                                                                                                       

  Latka 2009       stage 0 to stage IIIA breast cancer                         56.5(9.5)/NR                     37/38                                                                              6 months                                                                                                                                  Moderate                                     exercise goal was 30 min of exercise 5 days/week for\                                                                                                   \*BMI\                                                                                                                                      \*Women with higherBMI,\
                                                                                                                                                                                                                                                                                                                                                                                          6 months.\                                                                                                                                              \*waist circumference\                                                                                                                      larger waist circumference, fewer minutes of physical\
                                                                                                                                                                                                                                                                                                                                                                                          \*(Participants wereasked to\                                                                                                                           \*FACT-B\                                                                                                                                   activity at baseline\
                                                                                                                                                                                                                                                                                                                                                                                          perform three 15-minsessions during Week1,\                                                                                                             Breast Cancer subscale\                                                                                                                     associated with breast\
                                                                                                                                                                                                                                                                                                                                                                                          building to five 30min-sessions by Week5)                                                                                                               \*Transtheoretical Model Stage                                                                                                              cancer as measured by the FACT-B Breast Cancer subscale\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              score had a lower adherence to the exercise prescription.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \*Specifically,\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              a lower BMI and a higher degree of readiness to\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              change physical activity behavior were associated with\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              better adherence.
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

Shows Baseline-Characteristics of Included Studies Participants

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  study           Study arm        Sample Size\     Age\                                          Disease stage (%) In situ Stage I Stage II\   BMI\            Weight (kg)\            Menopausal status\      Time since diagnosis         Ethnicity (%)                Pedometer average, steps/d                                                                      Physical activity
                                   Experimental/\   mean (SD)                                     Stage IIIA                                    mean (SD)       mean (SD)               \*Pre-menopausal\                                                                                                                                                                 
                                   control                                                                                                                                              \*Post-menopausal                                                                                                                                                                 
  --------------- ---------------- ---------------- --------------------------------------------- --------------------------------------------- --------------- ----------------------- ----------------------- ---------------------------- ---------------------------- ----------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------
  Matthews 2007   Experimental     22               51.3 (9)                                      Stage I (59%)\                                28.3 (4.9)      74.9(14.5)              Post-menopausal         0.9\                         White 82%\                   7,409.4 (2,791.1)                                                                               \*By CHAMPS unit of MET-h/week:\
                                                                                                  Stage II /III (18%)\                                                                                          (0.7 -- 1)                   African American/other 18%                                                                                                   Total activity\
                                                                                                  Not available (23%)                                                                                                                                                                                                                                                     32.7 (24.0)

  control         14               56.9 (12.3)      Stage I (64%)\                                29.9 (7.1)                                    78.9(20.3)      Post-menopausal         0.7\                    White86%\                    5,939.00\                    \*By CHAMPS unit of MET-h/week:\                                                                
                                                    Stage II/III (21%)\                                                                                                                 (0.6 -- 1)              African American/other 14%   -2,203.50                    Total activity\                                                                                 
                                                    Not available (14%)                                                                                                                                                                                                   22.2 (20.7)                                                                                     

  Campbell 2017   Experimental     10               53.2 (7)                                      Stage I: 0\                                   26.3 (5.7)      71.1 (15.9)             Post-menopausal         NR                           NR                           NR                                                                                              (MET-hr./wk.)\
                                                                                                  Stage II: 10(100)\                                                                                                                                                                                                                                                      14.1 (12.0)
                                                                                                  Stage III:0                                                                                                                                                                                                                                                             

  control         9                51.4 (5.1)       Stage I: 0\                                   26.1 (5.5)                                    66.6 (16.7)     Post-menopausal         NR                      NR                           NR                           (MET-hr./wk.)\                                                                                  
                                                    Stage II: 7(78)\                                                                                                                                                                                                      11.2 (7.0)                                                                                      
                                                    Stage III: 2(22)                                                                                                                                                                                                                                                                                                      

  Roveda 2016     Experimental     19               55.2 (6.8)                                    NR                                            25.4 (3.8)      67.1 (11.9)             Pre & post-menopausal   NR                           NR                           9790.9 ± 2817.2                                                                                 physical activity level\
                                                                                                                                                                                                                                                                                                                                                                          1.49 ( 0.10)

  control         21               58.2 (6.4)       NR                                            24.6 (3.4)                                    64.5 (9.6)      Pre & post-menopausal   NR                      NR                           11001.6 ± 3702.2             physical activity level\                                                                        
                                                                                                                                                                                                                                                                          1.56 ( 0.14)                                                                                    

  Fairey 2005     Experimental     24               59 (5)                                        Stage I (42%)\                                29.4 (7.4)      78.1 (20.4)             Post-menopausal         NR                           NR                           NR                                                                                              fitness described in baseline values for peak oxygen consumption (ml/kg/min\
                                                                                                  Stage IIa (25%)\                                                                                                                                                                                                                                                        18.6 (3.9)
                                                                                                  Stage IIb (25%)\                                                                                                                                                                                                                                                        
                                                                                                  Stage IIIa (8%)                                                                                                                                                                                                                                                         

  control         28               58 (6)           Stage I (39%)\                                29.1 (6.1)                                    79.4 (16.4)     Post-menopausal         NR                      NR                           NR                           cardiopulmonary fitness described in baseline values for peak oxygen consumption (ml/kg/min)\   
                                                    Stage IIa (39%)\                                                                                                                                                                                                      18.8 (3.8)                                                                                      
                                                    Stage IIb (18%)\                                                                                                                                                                                                                                                                                                      
                                                    Stage IIIa\                                                                                                                                                                                                                                                                                                           
                                                    -4%                                                                                                                                                                                                                                                                                                                   

  Thomas 2013     Experimental     35               56.5 (9.8)                                    In situ (11%)\                                30.8 (5.9)      82.1 (16.5)             Post-menopausal         3.6 (2.2)                    White 83%\                   NR                                                                                              Physical activity questionnaire\
                                                                                                  Stage I (54%)\                                                                                                                             African American 17%\                                                                                                        13.0 (24.0)
                                                                                                  Stage II (26%)\                                                                                                                            Asian/Pacific Islander 0%                                                                                                    
                                                                                                  Stage IIIA\                                                                                                                                                                                                                                                             
                                                                                                  -9%                                                                                                                                                                                                                                                                     

  control         30               55.1 (7.6)       In situ (10%)\                                29.4 (7.4)                                    77.2 (20.4)     Post-menopausal         3.3 (2.6)               White 90%\                   NR                           Physical activity questionnaire\                                                                
                                                    Stage I (27%)\                                                                                                                                              African American 7%\                                      12.0 (20.0)                                                                                     
                                                    Stage II (47%)\                                                                                                                                             Asian/Pacific Islander 3%                                                                                                                                 
                                                    Stage IIIA (17%)                                                                                                                                                                                                                                                                                                      

  Study arm       Sample Size\     Age\             Disease stage (%) In situ Stage I Stage II\   BMI\                                          Weight (kg)\    Menopausal status\      Time since diagnosis    Ethnicity (%)                Pedometer average, steps/d   Physical activity                                                                               
                  Experimental/\   mean (SD)        Stage IIIA                                    mean (SD)                                     mean (SD)       \*Pre-menopausal\                                                                                                                                                                                         
                  control                                                                                                                                       \*Post-menopausal                                                                                                                                                                                         

  Experimental    37               56.5 (9.5)       In situ -11%\                                 30.4 (6.0)                                    NR              Post-menopausal         3.6 (2.2)               Non-Hispanic white 84%\      5145 (2,312)                 -Physical Activity Questionnaire\                                                               
                                                    Stage I -54%\                                                                                                                                               African American 16%\                                     13.0 (24.0)\                                                                                    
                                                    Stage II -27%\                                                                                                                                              Asian/Pacific Islander 0%                                 -Daily Activity Log, min/wk.\                                                                   
                                                    Stage IIIA -8%                                                                                                                                                                                                        recreational exercise\                                                                          
                                                                                                                                                                                                                                                                          30.0 (41.1)                                                                                     

  control         38               55.1 (7.7)       In situ -11%\                                 30.1 (7.4)                                    NR              Post-menopausal         3.3 (2.6)               Non-Hispanic white 84%\      5342 (2,744)                 -Physical Activity Questionnaire\                                                               
                                                    Stage I -27%\                                                                                                                                               African American 11%\                                     12.0 (20.0)\                                                                                    
                                                    Stage II -46%\                                                                                                                                              Asian/Pacific Islander 3%                                 -Daily Activity Log, min/wk.\                                                                   
                                                    Stage IIIA -16%                                                                                                                                                                                                       recreational exercise\                                                                          
                                                                                                                                                                                                                                                                          11.3 (24.8)                                                                                     

  Experimental    37               56.5 (9.5)       In situ -11%\                                 30.57 (5.95)                                  81.28 (16.98)   Post-menopausal         3.6 (2.2)               Non-Hispanic white 84%\      5.145 (2.312)                -Physical Activity Questionnaire\                                                               
                                                    Stage I -54%\                                                                                                                                               African American 16%\                                     13.0 (24.0)\                                                                                    
                                                    Stage II -27%\                                                                                                                                              Asian/Pacific Islander 0%                                 Daily activity log (min/week-\                                                                  
                                                    Stage IIIA -8%                                                                                                                                                                                                        recreational exercise)\                                                                         
                                                                                                                                                                                                                                                                          30.0 (41.1)                                                                                     

  control         38               55.1 (7.7)       In situ -11%\                                 29.74 (7.27)                                  78.4 (20.01)    Post-menopausal         3.3 (2.6)               Non-Hispanic white 84%\      5.342 (2.744)                -Physical Activity Questionnaire\                                                               
                                                    Stage I -27%\                                                                                                                                               African American 11%\                                     12.0 (20.0)\                                                                                    
                                                    Stage II -46%\                                                                                                                                              Asian/Pacific Islander 3%                                 -Daily activity log\                                                                            
                                                    Stage IIIA -16%                                                                                                                                                                                                       (min/wk. recreational exercise)\                                                                
                                                                                                                                                                                                                                                                          30.0 (41.1)                                                                                     

  Experimental    36               56.4 (9.5)       In situ -11%\                                 30.4 (6.0)                                    81.0 (16.8)     Post-menopausal         3.6 (2.2)               Non-Hispanic white 83%\      5,083 (2,312)                -Physical Activity Questionnaire\                                                               
                                                    Stage I -56%\                                                                                                                                               African American 17%\                                     13.0 (24.0)\                                                                                    
                                                    Stage II -25%\                                                                                                                                              Asian/Pacific Islander 0%                                 -Daily activity log\                                                                            
                                                    Stage IIIA -8%                                                                                                                                                                                                        (min/wk. recreational exercise)\                                                                
                                                                                                                                                                                                                                                                          30.0 (41.1)                                                                                     

  control         32               55.6 (7.7)       In situ -13%\                                 30.1 (7.4)                                    79.3 (21.3)     Post-menopausal         3.3 (2.6)               Non-Hispanic white 90%\      5,624 (2,744)                -Physical Activity questionnaire\                                                               
                                                    Stage I -25%\                                                                                                                                               African American 7%\                                      12.0 (20.0)\                                                                                    
                                                    Stage II -44%\                                                                                                                                              Asian/Pacific Islander 3%                                 - Daily activity log\                                                                           
                                                    Stage IIIA -19%                                                                                                                                                                                                       (min/wk. recreational exercise)\                                                                
                                                                                                                                                                                                                                                                          11.3 (24.8)                                                                                     

  Experimental    36               56.4 (9.6)       In situ -13%\                                 30.6 (6.0)                                    81.3 (17.0)     Post-menopausal         3.5 (2.1%)              Non-Hispanic white 83%\      5083 (2,313)                 -Physical activity questionnaire\                                                               
                                                    Stage I -25%\                                                                                                                                               African American 17%\                                     30.3 (41.4)                                                                                     
                                                    Stage II -44%\                                                                                                                                              Asian/Pacific Islander 0%\                                                                                                                                
                                                    Stage IIIA -19%                                                                                                                                             Unknown 0%                                                                                                                                                

  control         31               55.4 (7.6)       In situ -11%\                                 29.4 (7.3)                                    77.3 (20.0)     Post-menopausal         3.1 (2.4%)              Non-Hispanic white 87%\      5661 (2,740)                 -Physical activity questionnaire\                                                               
                                                    Stage I -56%\                                                                                                                                               African American 6%\                                      11.9 (31.3)                                                                                     
                                                    Stage II -25%\                                                                                                                                              Asian/Pacific Islander 3%\                                                                                                                                
                                                    Stage III -8%                                                                                                                                               Unknown 3%                                                                                                                                                

  Study arm       Sample Size\     Age\             Disease stage (%) In situ Stage I Stage II\   BMI\                                          Weight (kg)\    Menopausal status\      Time since diagnosis    Ethnicity (%)                Pedometer average, steps/d   Physical activity                                                                               
                  Experimental/\   mean (SD)        Stage IIIA                                    mean (SD)                                     mean (SD)       \*Pre-menopausal\                                                                                                                                                                                         
                  control                                                                                                                                       \*Post-menopausal                                                                                                                                                                                         

  Experimental    30               53 (11)          Stage I (33%)\                                25.9 (2.8)                                    74.0 (9.4)      NR                      NR                      NR                           NR                           physical\                                                                                       
                                                    Stage IIa (37%)\                                                                                                                                                                                                      performance assessment by\                                                                      
                                                    Stage IIb (20%)\                                                                                                                                                                                                      12min Walk\                                                                                     
                                                    Stage IIIa -10%                                                                                                                                                                                                       Test (12MWT)\                                                                                   
                                                                                                                                                                                                                                                                          799.6 (81)                                                                                      

  Control         32               51 (11)          Stage I (47%)\                                26.0 (3.3)                                    73.0 (10.5)     NR                      NR                      NR                           NR                           -physical\                                                                                      
                                                    Stage IIa (25%)\                                                                                                                                                                                                      performance assessment by\                                                                      
                                                    Stage IIb (22%)\                                                                                                                                                                                                      12min Walk\                                                                                     
                                                    Stage IIIa -6%                                                                                                                                                                                                        Test (12MWT)\                                                                                   
                                                                                                                                                                                                                                                                          814.4 (88.5)                                                                                    

  Experimental    37               56.5 (9.5)       In Situ 11%\                                  30.4 (6.0)                                    NR              Post-menopausal         3.6 (2.2)               Non-Hispanic white 84%\      5.145 (2.312)                Physical Activity Questionnaire-\                                                               
                                                    Stage I 54%\                                                                                                                                                African American 16%\                                     13.0 (24.0)\                                                                                    
                                                    Stage II 27%\                                                                                                                                               Asian/Pacific Islander 0%                                 -Daily Activity Log2\                                                                           
                                                    Stage IIIA 8%                                                                                                                                                                                                         30.0 (41.1)                                                                                     

  control         38               55.1 (7.7)       In situ 11%\                                  30.1 (7.4)                                    NR              Post-menopausal         3.3 (2.6)               Non-Hispanic white 84%\      5.342 (2,744)                -Physical Activity Questionnaire\                                                               
                                                    Stage I 27%\                                                                                                                                                African American 11%\                                     12.0 (20.0)                                                                                     
                                                    Stage II 46%\                                                                                                                                               Asian/Pacific Islander 3%                                                                                                                                 
                                                    Stage IIIA 16%                                                                                                                                                                                                                                                                                                        

  Experimental    76               55 (8)           NR                                            29.8 (6.2)                                    79.5 (17.1)     Pre & post-menopausal   54.2 (54.6)             NR                           NR                           -Physical activity measured\                                                                    
                                                                                                                                                                                                                                                                          by accelerometer (GT3X, Actigraph, Pensacola, FL)                                               

  control         76               55 (8)           NR                                            29.8 (6.2)                                    79.5 (17.1)     Pre & post-menopausal   54.2 (54.6)             NR                           NR                           -Physical activity measured\                                                                    
                                                                                                                                                                                                                                                                          by accelerometer (GT3X, Actigraph, Pensacola, FL)                                               

  Experimental    263              MEAN (range)\    NR                                            NR                                            NR              Pre & post-menopausal   NR                      NR                           NR                           \*Cardiorespiratory fitness was\                                                                
                                   52.3 (36-68)                                                                                                                                                                                                                           tested by a 2-km walk test\                                                                     
                                                                                                                                                                                                                                                                          18.6 (2.0)\                                                                                     
                                                                                                                                                                                                                                                                          \*Mean self-reported physical activity,\                                                        
                                                                                                                                                                                                                                                                          MET-hr./wk.\                                                                                    
                                                                                                                                                                                                                                                                          27.40 (16.54)                                                                                   

  control         237              MEAN (range)\    NR                                            NR                                            NR              Pre & post-menopausal   NR                      NR                           NR                           \*Cardiorespiratory fitness was\                                                                
                                   52.4 (35-68)                                                                                                                                                                                                                           tested by a 2-km walk test\                                                                     
                                                                                                                                                                                                                                                                          18.4 (1.8)\                                                                                     
                                                                                                                                                                                                                                                                          \*Mean self-reported physical activity,\                                                        
                                                                                                                                                                                                                                                                          MET-h/wk.\                                                                                      
                                                                                                                                                                                                                                                                          26.37 (15.69)                                                                                   

  Study arm       Sample Size\     Age\             Disease stage (%) In situ Stage I Stage II\   BMI\                                          Weight (kg)\    Menopausal status\      Time since diagnosis    Ethnicity (%)                Pedometer average, steps/d   Physical activity                                                                               
                  Experimental/\   mean (SD)        Stage IIIA                                    mean (SD)                                     mean (SD)       \*Pre-menopausal\                                                                                                                                                                                         
                  control                                                                                                                                       \*Post-menopausal                                                                                                                                                                                         

  Experimental    16               47.5 (7.1)       NR                                            NR                                            NR              NR                      NR                      white 70%\                   NR                           NR                                                                                              
                                                                                                                                                                                                                Black 12%\                                                                                                                                                
                                                                                                                                                                                                                Asian 12%\                                                                                                                                                
                                                                                                                                                                                                                Native American 6%                                                                                                                                        

  control         8                61.8 (8.1)       NR                                            NR                                            NR              NR                      NR                      white 88%\                   NR                           NR                                                                                              
                                                                                                                                                                                                                Black 12%\                                                                                                                                                
                                                                                                                                                                                                                Asian 0%\                                                                                                                                                 
                                                                                                                                                                                                                Native American 00%                                                                                                                                       

  Continuous      9                44.1 (4.6)       NR                                            30 (3.4)                                      75.4 (10.9)     Post-menopausal         NR                      NR                           NR                           NR                                                                                              

  Interval        8                44.1 (4.6)       NR                                            29.9 (2.8)                                    75.4 (6.6)      Post-menopausal         NR                      NR                           NR                           NR                                                                                              

  control         6                44.1 (4.6)       NR                                            30.9 (4.07)                                   81.7 (12.3)     Post-menopausal         NR                      NR                           NR                           NR                                                                                              
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Discussion
==========

This systematic review summarized the evidence on the effects of aerobic exercise interventions (especially walking as the most frequently investigated approach) in BC survivor women. The results showed that aerobic exercise was superior to usual care in enhancing the physical activity, QoL, and sleep parameters. However, weight and inflammatory markers did not show any remarkable difference between the two groups.

Moderate intensity aerobic exercise is associated with increased short-term physical activity levels among BC survivors, especially in patients who did not follow regular exercise before (Irwin et al., 2008; Matthews et al., 2007). However, Saarto et al., (2012) reported no significant difference between the exercise and control groups. This is explained by the considerable motivation and healthy lifestyle in the control group patients, which exerted a ceiling effect on the ability to detect the exercise benefits.

The observed increase in physical activity levels significally correlates with QoL improvement. The results of Murtezani et al., (2014) confirmed the causative relationship between moderate intensity aerobic exercise and QoL improvement. These results are supported by previous studies on the efficacy of aerobic exercise in improving the overall QoL (Burnham., 2002; McNeely et al., 2006). This improvement may be due to reducing anxiety and increasing energy in addition to counteracting some negative effects of cancer treatment (Jones et al., 2013; Meneses-Echávez et al., 2015; Murtezani et al., 2014).

Campbell et al., (2017) found that aerobic exercise ameliorated the resulting cognitive impairment from the psychological burden and cancer therapies. The results of this study come in accordance with a previous meta-analysis of 33 RCTs, which investigated the effects of exercise in general regarding the psychological outcomes, body composition and physical fuctions (Zhu et al., 2016). It concluded that exercise was beneficial for BC survivors because it improved the QoL, body configuration, and muscle strength, decreased serum levels of insulin, IGF-II, and IGFBP-1, and alleviated depression and anxiety.

Roveda et al., (2016) examined the effects of exercise on the sleep pattern. They reported significant improvement of sleep disturbance among BC survivors. Another study conducted by Thomas et al., (2013) revealed positive effects for aerobic exercise on reversing the metabolic syndrome in sedentry BC survivors. Another study examined the effect of aerobic exercise in untrained women in a meta-analysis framework. It included different age groups and exercise intensities and emphasized the golden role of early exercise intervention in improving the cardiovascular outcomes in sedentary women (Zhang et al., 2017).

*Strengths of the study*

We followed the PRISMA statement during performance and reporting of this review and conducted all steps in accordance to the cochrane handbook for systematic reviews of interventions. Reasons for patient discontinuation were appropriately addressed. Moreover, study investigators used as intention to treat approach so there would not be attrition bias. Studies included in this systematic review were low to moderate risk of bais according to Cochrane ROB assessment tool.

*Limitations of the study*

We selectively chose studies that investigated the benefits of aerobic exercise in BC survivors. We found scarce literature covering this pattern of exercise with diversity in the measured outcomes, intervention (type, intensity, and duration), and the used assessment methods. Therefor, the extracted data were not sufficient for subsequent pooled analysis. Future studies are recommended to study the effects of aerobic exercise in BC survivors for longer durations with including much important outcomes, such as inflammatory markers, sleep pattern, and other cancer contol measures.

*Clinical Implications*

The review findings supports that aerobic exercise intervention is beneficial to BC survivor women. It improves fatigue associated with BC by improving levels of physical activity, as well as QoL. It also enhances the stability of sleep among BC survivors (Matthews et al., 2007; Murtezani et al., 2014; Roveda et al., 2016).

*Key Practice Points*

\* Aerobic exercise should be recommended in the rehbailitation regimen of BC survivors.

\* The intensity and duration of exercise should be personalized to each patient and further research is needed in this regard.

In conclusion, despite the aforementioned limitations, there is evidence that aerobic exercise (mainly in the form of walking) was associated with beneficial outcomes in BC survivor women; It improved the Qol and alleviated the symptoms of depression and anxiety. Moreover, it enhanced the physical functioning and sleep pattern.

*Abbreviations*

BC: Breast Cancer, CRP: C - reactive protein, QoL: Quality of Life.
